Cover Image
Market Research Report
Product code 
1002933

Global In Situ Hybridization (ISH) Market 2021-2025

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global In Situ Hybridization (ISH) Market 2021-2025
Published: April 14, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the in situ hybridization (ISH) market and it is poised to grow by $ 475.05 mn during 2021-2025, progressing at a CAGR of about 7% during the forecast period. Our report on in situ hybridization (ISH) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing demand for companion diagnostic tests and product launches. In addition, increasing demand for companion diagnostic tests is anticipated to boost the growth of the market as well.

The in situ hybridization (ISH) market analysis includes technology segment, end-user segment, and geographic landscape.

Technavio's in situ hybridization (ISH) market is segmented as below:

By Technology

  • FISH
  • CISH

By End-user

  • Molecular diagnostic laboratories
  • Pharmaceutical and biotechnological companies
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing incidence and prevalence of cancer as one of the prime reasons driving the in situ hybridization (ISH) market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on in situ hybridization (ISH) market covers the following areas:

  • In situ hybridization (ISH) market sizing
  • In situ hybridization (ISH) market forecast
  • In situ hybridization (ISH) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in situ hybridization (ISH) market vendors that include Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the in situ hybridization (ISH) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40880

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Technology

  • Market segments
  • Comparison by Technology
  • FISH - Market size and forecast 2020-2025
  • CISH - Market size and forecast 2020-2025
  • COVID-19 impact and recovery for technology segment
  • Market opportunity by Technology

Market Segmentation by End-user

  • Market segments
  • Comparison by End user
  • Molecular diagnostic laboratories - Market size and forecast 2020-2025
  • Pharmaceutical and biotechnological companies - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • COVID-19 impact and recovery for end-user segment
  • Market opportunity by End user

Customer landscape

  • Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption
  • Industry risks

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corp.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Parent market
  • 10: Market characteristics
  • 11: Offerings of vendors included in the market definition
  • 12: Market segments
  • 13: Global - Market size and forecast 2020 - 2025 ($ million)
  • 14: Global market: Year-over-year growth 2020 - 2025 (%)
  • 15: Five forces analysis 2020 & 2025
  • 16: Bargaining power of buyers
  • 17: Bargaining power of suppliers
  • 18: Threat of new entrants
  • 19: Threat of substitutes
  • 20: Threat of rivalry
  • 21: Market condition - Five forces 2020
  • 22: Technology - Market share 2020-2025 (%)
  • 23: Comparison by Technology
  • 24: FISH - Market size and forecast 2020-2025 ($ million)
  • 25: FISH - Year-over-year growth 2020-2025 (%)
  • 26: CISH - Market size and forecast 2020-2025 ($ million)
  • 27: CISH - Year-over-year growth 2020-2025 (%)
  • 28: Market opportunity by Technology
  • 29: End user - Market share 2020-2025 (%)
  • 30: Comparison by End user
  • 31: Molecular diagnostic laboratories - Market size and forecast 2020-2025 ($ million)
  • 32: Molecular diagnostic laboratories - Year-over-year growth 2020-2025 (%)
  • 33: Pharmaceutical and biotechnological companies - Market size and forecast 2020-2025 ($ million)
  • 34: Pharmaceutical and biotechnological companies - Year-over-year growth 2020-2025 (%)
  • 35: Others - Market size and forecast 2020-2025 ($ million)
  • 36: Others - Year-over-year growth 2020-2025 (%)
  • 37: Market opportunity by End user
  • 38: Customer landscape
  • 39: Market share by geography 2020-2025 (%)
  • 40: Geographic comparison
  • 41: North America - Market size and forecast 2020-2025 ($ million)
  • 42: North America - Year-over-year growth 2020-2025 (%)
  • 43: Europe - Market size and forecast 2020-2025 ($ million)
  • 44: Europe - Year-over-year growth 2020-2025 (%)
  • 45: Asia - Market size and forecast 2020-2025 ($ million)
  • 46: Asia - Year-over-year growth 2020-2025 (%)
  • 47: ROW - Market size and forecast 2020-2025 ($ million)
  • 48: ROW - Year-over-year growth 2020-2025 (%)
  • 49: Key leading countries
  • 50: Market opportunity by geography ($ million)
  • 51: Impact of drivers and challenges
  • 52: Vendor landscape
  • 53: Landscape disruption
  • 54: Industry risks
  • 55: Vendors covered
  • 56: Market positioning of vendors
  • 57: Abbott Laboratories - Overview
  • 58: Abbott Laboratories - Business segments
  • 59: Abbott Laboratories - Key offerings
  • 60: Abbott Laboratories - Key customers
  • 61: Abbott Laboratories - Segment focus
  • 62: Agilent Technologies Inc. - Overview
  • 63: Agilent Technologies Inc. - Business segments
  • 64: Agilent Technologies Inc. - Key offerings
  • 65: Agilent Technologies Inc. - Key customers
  • 66: Agilent Technologies Inc. - Segment focus
  • 67: Bio-Rad Laboratories Inc. - Overview
  • 68: Bio-Rad Laboratories Inc. - Business segments
  • 69: Bio-Rad Laboratories Inc. - Key offerings
  • 70: Bio-Rad Laboratories Inc. - Key customers
  • 71: Bio-Rad Laboratories Inc. - Segment focus
  • 72: Bio-Techne Corp. - Overview
  • 73: Bio-Techne Corp. - Business segments
  • 74: Bio-Techne Corp. - Key offerings
  • 75: Bio-Techne Corp. - Key customers
  • 76: Bio-Techne Corp. - Segment focus
  • 77: F. Hoffmann-La Roche Ltd. - Overview
  • 78: F. Hoffmann-La Roche Ltd. - Business segments
  • 79: F. Hoffmann-La Roche Ltd. - Key offerings
  • 80: F. Hoffmann-La Roche Ltd. - Key customers
  • 81: F. Hoffmann-La Roche Ltd. - Segment focus
  • 82: Merck KGaA - Overview
  • 83: Merck KGaA - Business segments
  • 84: Merck KGaA - Key offerings
  • 85: Merck KGaA - Key customers
  • 86: Merck KGaA - Segment focus
  • 87: NeoGenomics Laboratories, Inc. - Overview
  • 88: NeoGenomics Laboratories, Inc. - Business segments
  • 89: NeoGenomics Laboratories, Inc. - Key offerings
  • 90: NeoGenomics Laboratories, Inc. - Key customers
  • 91: NeoGenomics Laboratories, Inc. - Segment focus
  • 92: PerkinElmer Inc. - Overview
  • 93: PerkinElmer Inc. - Business segments
  • 94: PerkinElmer Inc. - Key offerings
  • 95: PerkinElmer Inc. - Key customers
  • 96: PerkinElmer Inc. - Segment focus
  • 97: QIAGEN NV - Overview
  • 98: QIAGEN NV - Business segments
  • 99: QIAGEN NV - Key offerings
  • 100: QIAGEN NV - Key customers
  • 101: QIAGEN NV - Segment focus
  • 102: Thermo Fisher Scientific Inc. - Overview
  • 103: Thermo Fisher Scientific Inc. - Business segments
  • 104: Thermo Fisher Scientific Inc. - Key offerings
  • 105: Thermo Fisher Scientific Inc. - Key customers
  • 106: Thermo Fisher Scientific Inc. - Segment focus
  • 107: Currency conversion rates for US$
  • 108: Research Methodology
  • 109: Validation techniques employed for market sizing
  • 110: Information sources
  • 111: List of abbreviations